Clinical trial
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
NCT02338115 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- December 20, 2016
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer